Home
News
News archive
Diamond Information


home > news Federal officials call out FDA over lapses in rare-disease drug approval

Federal officials call out FDA over lapses in rare-disease drug approval




The Food and Drug Administration has failed to ensure that drugs given prized rare-disease status meet the intent of a 35-year-old law, federal officials revealed in a report Friday.



Click Here to read the entire article...



Find this article in Google